Q-linea AB (publ) (QLINEA) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Q-linea Ab.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:01.132 Hello, everyone. 00:00:01.132 -- 00:00:06.259 You have Stuart Gander here, CEO of Qlinia, and I'm joined by Krista Samuelsson, my CFO. 00:00:06.259 -- 00:00:11.406 Thank you for joining this Q4 report from Qlinia, our year-end report 00:00:11.406 -- 00:00:13.546 for 2025. 00:00:14.450 -- 00:00:18.055 Just a quick disclaimer up front on all forward-looking statements. 00:00:18.055 -- 00:00:21.699 We'll take that as read. So 00:00:21.699 -- 00:00:23.121 typical 00:00:23.121 -- 00:00:25.825 format for this presentation is we've had in the past. 00:00:25.825 -- 00:00:29.510 I'll spend some time here just giving you an update on the commercial progress for the 00:00:29.510 -- 00:00:33.836 company, some of the context and dynamics we see in the market. 00:00:33.836 -- 00:00:37.881 Then we'll share a little bit of how our customers are seeing that with their patient 00:00:37.881 -- 00:00:41.647 impact and some of the evidence that's coming out of usage 00:00:41.647 -- 00:00:43.910 in the real world, which we're very excited about. 00:00:43.910 -- 00:00:48.997 And then we'll start to look forward into 2026 before I'll hand over the reins to Krister, 00:00:48.997 -- 00:00:53.043 who will walk through the financials in our quarterly report. 00:00:53.043 -- 00:00:57.046 As ever, we'll wrap up the end with some Q&A. 00:00:57.330 -- 00:01:00.915 So with that, and for those who have very little time and just want the highlights, a 00:01:00.915 -- 00:01:04.160 few key messages to walk away from on this report. 00:01:04.160 -- 00:01:06.921 So first of all, 2025 00:01:06.965 -- 00:01:09.869 did generate significant growth in the top line. 00:01:09.869 -- 00:01:15.136 So we're more than 4x greater than previous year. 00:01:15.136 -- 00:01:20.142 We'...